Diabetes drug Actos tied to increased bladder cancer risk

more+
less-

The Food and Drug Administration has announced the use of the diabetes drug Actos for more than one year can increase a patient’s risk of developing bladder cancer. The agency says that it will add a new warning about the link between Actos and bladder cancer to the drug’s label later this year.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Personal Injury Updates, Products Liability Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Hissey Kientz LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »